HealthcareServices

Coronary Artery Disease Market Forecast: What to Expect by 2029

November 24, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Coronary Artery Disease Market Between 2025 And 2029?

The coronary artery disease market has experienced substantial growth in recent years. It is projected to increase from $29.15 billion in 2024 to $31.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.4%. This historical growth can be attributed to the prevalence of coronary artery disease, the expansion of minimally invasive surgeries, an increase in sedentary lifestyles, the aging population along with CAD prevalence, and the evolution of pharmacological treatments.

The coronary artery disease market size is projected to experience swift expansion in the coming years. It is anticipated to reach $48.27 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period is attributable to increasing lifestyle factors, an emphasis on telemedicine and remote patient monitoring, the proliferation of interventional cardiology procedures, a transition to value-based healthcare models, and the creation of new drug therapies. Key trends during the forecast period encompass the advancement of gene therapies, the incorporation of artificial intelligence in diagnostics, increased attention to mental health within CAD management, the emergence of home-based healthcare services, and the uptake of remote cardiac rehabilitation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp

What Are The Top Growth Drivers Impacting The Coronary Artery Disease Market Outlook?

An increase in the occurrence of coronary artery disease is anticipated to drive expansion in the coronary artery disease market in the years ahead. Coronary artery disease, abbreviated as CAD, is a medical state defined by the constriction or obstruction of the coronary arteries, responsible for delivering blood to the cardiac muscle. Instances of coronary artery disease are growing owing to evolving dietary habits, elevated stress levels, insufficient physical activity, widespread obesity, advancing age, among other factors. Management of coronary artery disease involves pharmaceutical interventions like clopidogrel, ticagrelor, warfarin, and heparin, alongside surgical procedures including coronary artery bypass grafting, angioplasty, and stenting. As an illustration, in May 2024, data from the Centre of Disease control and prevention, a federal agency in the U.S. Department of Health and Human Services, indicated that coronary heart disease (CHD) was the primary form of heart disease, leading to 371,506 fatalities in 2022. Approximately 5% of individuals aged 20 and above (which is 1 in 20) suffered from coronary artery disease (CAD). During 2022, roughly 1 in 5 deaths attributed to cardiovascular disease (CVD) were observed in adults under 65 years of age. Consequently, the expanding prevalence of coronary artery disease is projected to stimulate the coronary artery disease market throughout the forecast period.

How Is The Coronary Artery Disease Market Classified Into Different Segments?

The coronary artery diseasemarket covered in this report is segmented –

1) By Treatment: Medication; Surgery; Additional Therapy; Other Treatments

2) By Diagnosis: Electrocardiogram; Echocardiogram; Stress Test; Cardiac Catheterization; Heart CT Scan; Other Diagnosis

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Channels

4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Medication: Antiplatelet Agents; Beta-Blockers; Statins; ACE Inhibitors; Other Medications

2) By Surgery: Coronary Artery Bypass Grafting; Angioplasty And Stenting; Heart Valve Surgery; Other Surgical Interventions

3) By Additional Therapy: Cardiac Rehabilitation; Lifestyle Modification Programs; Alternative Therapies

4) By Other Treatments: Gene Therapy; Stem Cell Therapy; Innovative Devices

What Trends Are Expected To Drive The Coronary Artery Disease Market?

Leading companies in the coronary artery disease market are concentrating on the development of advanced technologies, such as AI-based blood tests, to gain a competitive advantage. An AI-based blood test refers to a diagnostic procedure that incorporates artificial intelligence (AI) algorithms for the analysis and interpretation of blood-related data. For instance, in February 2023, Cardio Diagnostics Holdings, a US-based AI-based integrated genetic-epigenetic engine manufacturing company, announced the introduction of PrecisionCHD. This is a combined genetic and epigenetic blood test designed for the early identification of coronary heart disease. PrecisionCHD shows over 75% sensitivity for detecting coronary heart disease in both men and women. Utilizing a machine-learning model derived from the analysis of billions of genomic and epigenomic data points, the test integrates epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

Who Are The Primary Competitors In The Global Coronary Artery Disease Market?

Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Coronary Artery Disease Market?

North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Coronary Artery Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp

Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2025, By The Business Research Company

Motor Vehicle And Parts Dealers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/motor-vehicle-and-parts-dealers-global-market-report

Automobiles And Heavy Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automobiles-and-heavy-equipment-global-market-report

Electric Motor And Generator Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795